Lilly And Novo Nordisk Shape Up For Obesity Treatment Battle Of The Heavyweights
Key Phase III Readouts Soon
Lilly's drug outperformed Novo's in a head-to-head in diabetes, but is now aiming for superiority in obesity treatment as well. • Source: Michael Vi / Shutterstock.com
